DK2086552T3 - Azithromycin til behandling af nodulær acne vulgaris - Google Patents

Azithromycin til behandling af nodulær acne vulgaris

Info

Publication number
DK2086552T3
DK2086552T3 DK07838730.5T DK07838730T DK2086552T3 DK 2086552 T3 DK2086552 T3 DK 2086552T3 DK 07838730 T DK07838730 T DK 07838730T DK 2086552 T3 DK2086552 T3 DK 2086552T3
Authority
DK
Denmark
Prior art keywords
azithromycin
treatment
acne vulgaris
nodular acne
nodular
Prior art date
Application number
DK07838730.5T
Other languages
English (en)
Inventor
Gordon Jay Dow
Bhaskar Chaudhuri
Barry Calvarese
David Wade Osborne
Original Assignee
Dow Pharmaceutical Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Pharmaceutical Sciences filed Critical Dow Pharmaceutical Sciences
Application granted granted Critical
Publication of DK2086552T3 publication Critical patent/DK2086552T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203Retinoic acids ; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
DK07838730.5T 2006-10-03 2007-09-24 Azithromycin til behandling af nodulær acne vulgaris DK2086552T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84906506P 2006-10-03 2006-10-03
US11/635,127 US7704959B2 (en) 2006-10-03 2006-12-06 Azithromycin for the treatment of nodular acne
PCT/US2007/020583 WO2008042139A2 (en) 2006-10-03 2007-09-24 Azithromycin for the treatment of nodular acne

Publications (1)

Publication Number Publication Date
DK2086552T3 true DK2086552T3 (da) 2012-01-09

Family

ID=39261797

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07838730.5T DK2086552T3 (da) 2006-10-03 2007-09-24 Azithromycin til behandling af nodulær acne vulgaris

Country Status (19)

Country Link
US (2) US7704959B2 (da)
EP (2) EP2420240B1 (da)
JP (1) JP2010505827A (da)
KR (1) KR20090064592A (da)
CN (2) CN101534837B (da)
AT (1) ATE533496T1 (da)
AU (1) AU2007302663B2 (da)
BR (1) BRPI0719535A2 (da)
CA (1) CA2664673A1 (da)
CY (1) CY1112650T1 (da)
DK (1) DK2086552T3 (da)
ES (2) ES2574677T3 (da)
HK (1) HK1130667A1 (da)
MX (1) MX2009003484A (da)
PL (2) PL2420240T3 (da)
PT (1) PT2086552E (da)
RU (1) RU2009116629A (da)
SI (1) SI2086552T1 (da)
WO (1) WO2008042139A2 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8124123B2 (en) * 2007-09-05 2012-02-28 Dow Pharmaceutical Sciences, Inc. Controlled release azithromycin solid dosages forms
US8143227B2 (en) * 2007-09-05 2012-03-27 Dow Pharmaceutical Sciences, Inc. Azithromycin for treatment of skin disorders
CN107281155B (zh) * 2017-06-06 2020-04-10 扬子江药业集团四川海蓉药业有限公司 一种阿奇霉素片及其制备方法
CA3070663A1 (en) * 2017-07-21 2019-01-24 Almirall, Llc Treatment of non-inflammatory lesions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474758A (en) 1981-11-19 1984-10-02 American Cyanamid Company Haemophilus influenzae type b and pertussis outer membrane component combined vaccine
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4474766A (en) 1983-06-27 1984-10-02 Merck & Co., Inc. Anti-inflammatory/analgesic combination of cyclo-(N-methyl-Ala-Tyr-D-Trp-Lys-Val-Phe) and a selected non-steroidal anti-inflammatory drug (NSAID)
RO107257B1 (ro) 1987-07-09 1993-10-30 Pfizer Procedeu de obtinere a unui dihidrat de azitromicina, cristalin
FR2710841B1 (fr) * 1993-10-05 1995-11-17 Oreal Composition cosmétique ou pharmaceutique pour la peau, anhydre et stable, à base de rétinol et son utilisation en vue du traitement des maladies de la peau.
GB9723669D0 (en) * 1997-11-07 1998-01-07 Univ Aberdeen Skin penetration enhancing components
PT1383508E (pt) * 2001-04-05 2006-11-30 Collagenex Pharm Inc Doxiciclina destinada ao tratamento da acne
US7211267B2 (en) 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
HRP20010301A2 (en) * 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
US9035741B2 (en) * 2003-06-27 2015-05-19 Stryker Corporation Foot-operated control console for wirelessly controlling medical devices

Also Published As

Publication number Publication date
PT2086552E (pt) 2011-12-19
HK1130667A1 (en) 2010-01-08
EP2086552B1 (en) 2011-11-16
SI2086552T1 (sl) 2012-01-31
JP2010505827A (ja) 2010-02-25
US7704959B2 (en) 2010-04-27
AU2007302663B2 (en) 2012-07-12
ES2377470T3 (es) 2012-03-27
CN102614210A (zh) 2012-08-01
WO2008042139A3 (en) 2008-10-16
EP2420240B1 (en) 2016-05-11
ES2574677T3 (es) 2016-06-21
US20080081790A1 (en) 2008-04-03
MX2009003484A (es) 2009-10-26
CN101534837A (zh) 2009-09-16
CA2664673A1 (en) 2008-04-10
CN101534837B (zh) 2012-04-04
US20100216732A1 (en) 2010-08-26
PL2420240T3 (pl) 2016-10-31
RU2009116629A (ru) 2010-11-10
PL2086552T3 (pl) 2012-03-30
AU2007302663A1 (en) 2008-04-10
EP2086552A4 (en) 2009-11-04
EP2420240A1 (en) 2012-02-22
ATE533496T1 (de) 2011-12-15
EP2086552A2 (en) 2009-08-12
KR20090064592A (ko) 2009-06-19
WO2008042139A2 (en) 2008-04-10
BRPI0719535A2 (pt) 2014-01-14
CY1112650T1 (el) 2016-02-10

Similar Documents

Publication Publication Date Title
NL300936I2 (nl) Semaglutide
WO2007095638A3 (en) Boron-containing small molecules as anti-inflammatory agents
MX2007000611A (es) Tratamiento de la piel con luz y un agente benefico para mitigar el acne.
BRPI0607379B8 (pt) composição farmacêutica de efeito analgésico
MX2009006536A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
RS52784B (en) They're TANATE RAZAGILINA
RS52780B (en) MEANS OF PREVENTION AND TREATMENT OF DISORDERS CONCERNING MODULATION OF RYR RECEPTORS
DE602007009399D1 (de) Hydrocyanierungsverfahren mit verminderten ertragsverlusten
WO2006135789A3 (en) Fiber-coupled single photon source
MX2008007808A (es) Analogos de rifamicina y usos de ellos.
RS52255B (en) NALMEFEN HYDROCHLORIDE DIHYDRATE
TW200731177A (en) Display system
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
HK1164114A1 (en) Antidepressant containing heterocyclic compound having specific structure
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
CY1113916T1 (el) Παραγωγα ετεροαρυλο πυρρολιδινυλο και πιπεριδινυλο κετονης
DK2086552T3 (da) Azithromycin til behandling af nodulær acne vulgaris
ATE549313T1 (de) Verbindungen mit antitumorwirkung
WO2008111265A1 (ja) 表示装置用照明装置、表示装置
NO20092496L (no) Ny terapeutisk anvendelse for behandling av leukemi
ATE502918T1 (de) Arylsulfonamide mit analgetischer wirkung
DE602006005190D1 (de) Beleuchtungsvorrichtung mit reduziertem Platzbedarf
WO2011104072A3 (de) Lampe mit zumindest einer lichtquelle und einem elektronischen betriebsgerät
DK2089229T3 (da) Inkjetdyseenhed med termisk bøjningsaktuator med en aktiv bærer, der definerer en væsentlig del af dysekammerets tag
WO2007127908A3 (en) Dihydrobenzoquinone compounds